As the FDA considers an overhaul of the advisory committee process, the agency is asking for public input on how the panels are used and how their purpose can be made clearer.
The agency announced plans to hold a public meeting on June 13 to discuss how it can best assemble committees and communicate their purpose to the public, among other topics. FDA Commissioner Robert Califf has hinted at upcoming systemic reforms to the adcomm system and has said he’d like to move away from voting in many scenarios.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.